This ~225KL capacity multi-product facility at Vizag was inspected for the first time by USFDA in November 2016 and has now received Establishment Inspection Report (EIR) from US FDA. The receipt of the EIR will enable Alivira's entry into $8 billion US veterinary healthcare market.